We advise raising cash, selling lower-quality stocks, and holding ETFs for safety amid potential recession risks. Read more ...
Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination to dig into the details of Novo's CB1 weight-loss pill and discuss how the company is looking to bring down the cost of ...